From: How to select IgG subclasses in developing anti-tumor therapeutic antibodies
 | IgG1 | IgG2 | IgG3 | IgG4 |
---|---|---|---|---|
Molecular mass (kD) | 146 | 146 | 170 | 146 |
Amino acids in hinge region | 15 | 12 | 62 | 12 |
Inter-heavy chain disulfide bonds | 2 | 4 | 11 | 2 |
Complement activation (C1q binding) | ++ | + | +++ | — |
FcγRI | 650 | — | 610 | 340 |
FcγRIIa-H131 | 52 | 4.5 | 8.9 | 1.7 |
FcγRIIa-R131 | 35 | 1 | 9.1 | 2.1 |
FcγRIIb | 1.2 | 0.2 | 1.7 | 2 |
FcγRIIIa-V158 | 20 | 0.7 | 98 | 2.5 |
FcγRIIIa-F158 | 11.7 | 0.3 | 77 | 2 |